Feb 4 (Reuters) - Biotech firm PrimeGen US will go public in the United States through a $1.5 billion deal with blank-check ...
A clinical-trial provider sued psychedelic therapy developer Definium Therapeutics on Monday in Delaware federal court, ...
Scorpius Biomanufacturing's former site of operations is now the base for California company's subsidiary, which will develop ...
Choose South Florida Business Journal as a preferred news source to see more of our reporting on Google.
A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...
Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...
Artificial intelligence (AI) isn't the only industry with explosive growth potential.
SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...
The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...
Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the ...
ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...
Feb 4 (Reuters) - Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results